Senate Joint Resolution No. 18-Committee on
Commerce and Labor
May 7, 1997
____________
Referred to Committee on Commerce and Labor
SUMMARY--Urges Congress to reform Food and Drug Administration to ensure that health care products, therapies and cures are available to public in timely manner. (BDR R-1559)
FISCAL NOTE: Effect on Local Government: No.
Effect on the State or on Industrial Insurance: No.
EXPLANATION - Matter in italics is new; matter in brackets [ ] is material to be omitted.
SENATE JOINT RESOLUTION--Urging Congress to reform the Food and Drug Administration to ensure that health care products, therapies and cures are available to the public in a timely manner.
Whereas, Better health care for all Americans is a significant national goal and one component to improved health care is the development and approval of safe and effective health care products, therapies and cures; and
Whereas, New products, therapies and cures derived from medical technology are improving the lives of millions of Americans and with meaningful reform of the Food and Drug Administration, could significantly reduce the cost of health care; and
Whereas, Minimizing delays between the creation and approval of a new product derived from the advances of medical technology is a vital public health goal; and
Whereas, The competitiveness and success of industries based on biotechnology, medical devices and pharmaceutical products in the United States is dependent upon the ability of those industries to market new products in a timely manner; now, therefore, be it
Resolved by the Senate and Assembly of the State of Nevada, Jointly, That the members of the Nevada Legislature respectfully urge Congress to address this important issue by enacting comprehensive legislation to reform the governing statutes and operation of the Food and Drug Administration to ensure that health care products, therapies and cures can be brought to the market as quickly as possible while preserving the safety of all Americans; and be it further
Resolved, That it is imperative that the Federal Government be responsive to the changing health care market and ensure that the excellence of innovation in medicine in the United States be maintained; and be it further
Resolved, That the Secretary of the Senate prepare and transmit a copy of this resolution to the Vice President of the United States as the presiding officer of the Senate, the Speaker of the House of Representatives, each member of the Nevada Congressional Delegation and the Commissioner of the Food and Drug Administration; and be it further
Resolved, That this act becomes effective upon passage and approval.